Content Library
GenScript Interview
Raymond Miller, Ph.D. Senior Global Product Manager, Therapeutic Materials GenScript Biotech Corporation
Using Predictive Bioinformatics Algorithms to Determine Neoantigen Peptide Synthesis Difficulty & Subsequent Production Methodology
Past Presentations from the Neoantigen Event Series
Jessica Baker Flechtner, Chief Scientific Officer, Genocea Biosciences
Beyond Algorithms: The ATLAS Bioassay Method for Neoantigen Identification and Characterization

Andrew Allen, CEO, Gritstone Oncology
Using Normal Immune Responses as Engine for Cancer Immunotherapy

Gavin MacBeath, Chief Scientific Officer, TScan Therapeutics
A Genome-Wide Approach to Discovering Novel Targets & TCRs for T-Cell Therapy

Hans-Peter Gerber, CSO & SVP, 3T Biosciences
Identification of Novel Shared Targets in Solid Tumors
